V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210001184 | 210013092 | null | null | Neo-adjuvant (N) | null | 2017-09-29 | CARBOPLATIN | N | N | CAPECITABINE + PERTUZUMAB + TRASTUZUMAB | 100896768 |
| 210001961 | 210013098 | 1.78 | 0 | null | 2020-10-28 | 2020-11-04 | Capecitabine | null | null | CAPECITABINE | 101469850 |
| 210001963 | 210013099 | 1.63 | 57.85 | Adjuvant (A) | 2020-02-16 | 2020-04-21 | Capecitabine | 02 | N | CAPECITABINE | 101232145 |
| 210002038 | 210013102 | 0 | 61.8 | Palliative (P) | 2021-04-16 | 2021-05-15 | Capecitabine | 02 | N | CAPECITABINE | 101316970 |
| 210002052 | 210013103 | 1.55 | null | null | 2021-06-09 | 2021-06-16 | FEC 100 | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100843902 |
| 210002107 | 210013105 | 1.66 | 68.2 | null | 2019-06-03 | 2019-08-19 | Capecitabine | 02 | null | CAPECITABINE | 101536240 |
| 210002144 | 210013107 | 1.63 | 78.7 | null | 2020-10-04 | 2020-10-19 | EC + PACLITAXEL | 02 | null | BLEOMYCIN | 100163344 |
| 210002229 | 210013108 | 1.58 | 63 | Palliative (P) | 2020-04-03 | 2020-04-23 | null | 02 | N | LETROZOLE + PALBOCICLIB | 101584469 |
| 210002362 | 210013109 | 1.66 | 53.9 | null | 2019-05-16 | 2019-05-24 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100908757 |
| 210002412 | 210013110 | 1.71 | 78.5 | null | 2020-10-20 | 2020-10-31 | Paclitaxel+Trastuzumab wkly Maint | null | null | PACLITAXEL + TRASTUZUMAB | 100071313 |
| 210002467 | 210013113 | 1.64 | 53.8 | Palliative (P) | 2021-08-13 | 2021-09-03 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100194392 |
| 210002751 | 210013115 | null | null | Palliative (P) | 2019-05-21 | 2019-06-06 | CAPECITABINE + CARBOPLATIN | 02 | N | FULVESTRANT + PALBOCICLIB | 100755182 |
| 210002805 | 210013116 | 1.57 | 72.7 | Neo-adjuvant (N) | null | 2017-06-10 | PERTUZUMAB + TRASTUZUMAB | Y | N | PERTUZUMAB + TRASTUZUMAB | 101615942 |
| 210002942 | 210013117 | 1.7 | 83.5 | Curative (C) | null | 2021-01-19 | Epirubicin (weekly) | null | null | ROSCO TRIAL | 101053988 |
| 210003324 | 210013120 | null | 87 | null | 2022-01-27 | 2022-02-17 | Capecitabine | 02 | null | EPIRUBICIN | 100837867 |
| 210003439 | 210013121 | null | 85.4 | null | 2017-09-07 | 2017-12-28 | null | 02 | null | ABEMACICLIB + FULVESTRANT | 100457558 |
| 210003473 | 210013123 | 1.47 | 63 | null | 2021-03-31 | 2021-04-13 | Capecitabine | 01 | null | CYCLOPHOSPHAMIDE + METHOTREXATE | 100851270 |
| 210003476 | 210013124 | 1.72 | 56.2 | null | 2020-02-19 | 2020-02-26 | null | 01 | null | LETROZOLE + PALBOCICLIB | 100010778 |
| 210003521 | 210013125 | 1.71 | 63.1 | null | 2019-01-16 | 2019-01-16 | null | 02 | null | LETROZOLE + PALBOCICLIB | 100132424 |
| 210003548 | 210013126 | 1.66 | 72.7 | Neo-adjuvant (N) | null | 2019-09-23 | Neratinib | null | N | NERATINIB | 100525179 |
| 210003725 | 210013128 | 1.58 | 94.6 | 03 | 2019-10-31 | 2020-01-11 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100388097 |
| 210003827 | 210013129 | 1.64 | 72.4 | null | 2022-04-17 | 2022-05-15 | null | null | null | PACLITAXEL + TRASTUZUMAB | 100114946 |
| 210003879 | 210013131 | 1.71 | 57.45 | Palliative (P) | 2021-04-06 | 2021-06-18 | GemCarbo Days 1+8 | 02 | N | TRIAL UNSPECIFIED | 100017528 |
| 210003424 | 210013274 | 1.62 | 66.3 | Palliative (P) | 2019-10-26 | 2020-02-23 | Paclitaxel 7 day | null | N | PACLITAXEL | 100219252 |
| 210003425 | 210013275 | 1.55 | 60.7 | Palliative (P) | 2020-03-06 | 2021-03-15 | PACLITAXEL | 02 | N | PACLITAXEL | 100143422 |
| 210003426 | 210013276 | null | 122.9 | null | null | 2019-02-22 | Trastuzumab | null | null | TRASTUZUMAB | 101846842 |
| 210003428 | 210013277 | 1.64 | 73.1 | Adjuvant (A) | 2021-01-01 | 2021-03-14 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100592120 |
| 210003431 | 210013278 | 1.52 | null | Adjuvant (A) | 2020-06-09 | 2020-09-04 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100614570 |
| 210003432 | 210013279 | 1.56 | 77.2 | Adjuvant (A) | 2022-01-21 | 2022-03-29 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101833996 |
| 210003435 | 210013280 | null | null | null | 2020-08-24 | 2020-12-13 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | PACLITAXEL | 101535177 |
| 210003439 | 210013281 | 1.72 | 75.9 | Adjuvant (A) | 2019-08-09 | 2020-06-15 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100457558 |
| 210003440 | 210013282 | null | 75.5 | Curative (C) | 2020-05-29 | 2020-08-14 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101566652 |
| 210003451 | 210013284 | 1.6 | 56.7 | Adjuvant (A) | null | 2020-01-29 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100951861 |
| 210003452 | 210013285 | 1.6 | 97.6 | Palliative (P) | 2019-12-27 | 2020-03-08 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101775997 |
| 210003464 | 210013286 | 1.66 | 85.7 | null | null | 2018-08-22 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101854779 |
| 210003467 | 210013287 | 1.73 | 112.8 | null | 2021-11-01 | 2022-03-22 | Docetaxel | null | N | DOCETAXEL | 101178524 |
| 210003468 | 210013288 | 1.56 | 70.8 | null | 2020-04-22 | 2020-06-02 | PACLITAXEL | null | null | PACLITAXEL | 100903040 |
| 210003472 | 210013290 | 1.54 | 57 | Neo-adjuvant (N) | 2020-01-13 | 2020-01-29 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101457043 |
| 210003483 | 210013293 | null | null | Adjuvant (A) | 2021-11-21 | 2021-12-19 | Docetaxel | 02 | N | DOCETAXEL | 100054786 |
| 210003490 | 210013294 | null | 88.9 | Adjuvant (A) | null | 2020-10-31 | Trastuzumab | 02 | N | TRASTUZUMAB | 100177487 |
| 210003491 | 210013295 | 1.64 | 62.4 | null | 2020-11-14 | 2020-12-06 | Docetaxel | null | null | DOCETAXEL | 100591677 |
| 210003497 | 210013296 | null | 75 | Palliative (P) | 2021-05-28 | 2021-07-31 | Trastuzumab | 02 | null | TRASTUZUMAB | 101680730 |
| 210003501 | 210013297 | 1.7 | 58.5 | Adjuvant (A) | null | 2021-01-22 | Trastuzumab Subcutaneous | null | null | TRASTUZUMAB | 101043228 |
| 210003502 | 210013298 | 1.56 | 84.5 | Palliative (P) | null | 2020-03-07 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100410458 |
| 210003504 | 210013299 | 1.62 | 50.8 | Adjuvant (A) | null | 2018-12-08 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101572966 |
| 210003511 | 210013300 | 1.65 | 84 | null | 2017-12-29 | 2018-03-09 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101358189 |
| 210003512 | 210013301 | 1.55 | 84.7 | Adjuvant (A) | 2017-06-06 | 2020-02-03 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101860377 |
| 210003515 | 210013302 | 1.66 | 85.1 | null | null | 2019-03-28 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100708990 |
| 210003525 | 210013303 | 1.65 | null | Palliative (P) | 2020-04-14 | 2020-06-19 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100811853 |
| 210003533 | 210013304 | 1.58 | 102.7 | null | 2017-06-07 | 2017-08-10 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100241636 |